Table 2.
NOPR post-PET intended management plan
| NOPR Intended Management | Cancer Type | |||||||
|---|---|---|---|---|---|---|---|---|
| All | Bladder | Kidney | Ovary | Pancreas | Prostate | SCL* | Stomach | |
| Patients | 8,460 | 1,127 | 1,070 | 2,075 | 862 | 1,974 | 720 | 632 |
| Treatment. N, (%) | 3,835 (45.3) | 504 (44.7) | 395 (36.9) | 1,095 (52.8) | 420 (48.7) | 842 (42.6) | 352 (48.9) | 227 (35.9) |
| Systemic therapy only | 2347 (27.7) | 261 (23.1) | 222 (20.7) | 811 (39.1) | 265 (30.7) | 428 (21.7) | 226 (31.4) | 134 (21.2) |
| Radiation only | 564 (6.7) | 71 (6.3) | 48 (4.5) | 84 (4.0) | 48 (5.6) | 273 (13.8) | 65 (9.0) | 13 (2.1) |
| Surgery only | 294 (3.5) | 50 (4.4) | 51 (4.8) | 52 (2.5) | 33 (3.8) | 33 (1.7) | 6 (0.8) | 34 (5.4) |
| Combination therapies‡ | 631 (7.5) | 123 (10.9) | 74 (6.9) | 151 (7.3) | 74 (8.6) | 108 (5.5) | 55 (7.6) | 46 (7.3) |
| Plans including therapy | ||||||||
| With systemic therapy | 2,944 (34.8) | 380 (33.7) | 291 (27.2) | 955 (46.0) | 338 (39.2) | 527 (26.7) | 278 (38.6) | 175 (27.7) |
| With radiation | 1,046 (12.4) | 173 (15.4) | 112 (10.5) | 113 (5.4) | 114 (13.2) | 374 (18.9) | 116 (16.1) | 44 (7.0) |
| With surgery | 540 (6.4) | 91 (8.1) | 76 (7.1) | 186 (9.0) | 53 (6.1) | 61 (3.1) | 15 (2.1) | 58 (9.2) |
| Biopsy | 939 (11.1) | 150 (13.3) | 146 (13.6) | 176 (8.5) | 74 (8.6) | 248 (12.6) | 60 (8.3) | 85 (13.4) |
| Watching | 3,686 (43.5) | 473 (42.0) | 529 (49.4) | 804 (38.7) | 368 (42.7) | 884 (44.7) | 308 (42.8) | 320 (50.6) |
*
SCL: Small cell lung
‡
Combination therapies: systemic therapy ± radiotherapy ± surge